GT BIOPHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.128 USD | -3.75% |
|
-3.15% | -59.11% |
| Mar. 26 | GT Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 01 | GT Biopharma to Conduct 1-for-30 Reverse Stock Split; Shares Fall | MT |
Chart calendar GT Biopharma, Inc.
0b1f0e7467382512ea29c3127c68a4._QmhLVyDcspVrFm0VpBHSM-eTmwT_X9AU8o-zfnQt4c.z3znbxHJGb0NnSvsJKQNMYbkPRpFrjF5OIxo-MC938SXQup8CdFBjD3CKg~850e4875494e831244911f6b81362b5c
Upcoming events on GT Biopharma, Inc.
Past events on GT Biopharma, Inc.
| 2024-05-12 | Q1 2024 Earnings Release (Projected) |
| 2023-12-18 02:00 pm | Extraordinary Shareholders Meeting |
| 2023-11-04 10:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract No:1180 |
| 2023-11-04 02:55 pm | Society for Immunotherapy of Cancer Meeting - Abstract No:1180 |
| 2023-11-01 09:00 am | Q3 2023 Earnings Release |
| 2023-08-17 03:30 pm | H.C. Wainwright Immune Cell Engager Conference |
| 2023-08-07 09:00 am | Q2 2023 Earnings Release |
| 2023-06-28 02:00 pm | Annual General Meeting |
| 2023-05-24 | ASTCT EBMT Joint Basic and Translational Scientific Meeting |
| 2023-05-16 09:00 am | PEGS Boston Conference |
| 2023-05-15 05:00 pm | Q1 2023 Earnings Release |
| 2023-03-30 05:00 pm | Q4 2022 Earnings Release |
| 2023-02-28 09:00 am | H.C. Wainwright Cell Therapy Virtual Conference |
| 2022-12-12 06:00 pm | American Society of Hematology Meeting - Abstract Number: 4623 |
| 2022-11-11 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204 |
| 2022-11-11 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202 |
| 2022-10-31 05:15 pm | Q3 2022 Earnings Release |
| 2022-10-26 07:30 pm | LD Micro Main Event Conference |
| 2022-10-10 02:00 pm | Extraordinary Shareholders Meeting |
| 2022-09-27 | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -6,76 -6,10 -10.89% | -57,5 -46,2 -24.59% | -21,3 -21,2 -0.2% | -13,6 -13,9 2.65% | -17,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -28,3 -16,9 -67.12% | -58,0 -46,6 -24.61% | -20,9 -21,5 2.87% | -7,60 -8,17 7.04% | -17,4 |
|
Net income Million USD | Released Forecast Spread | -38,6 | -28,3 -16,9 -67.12% | -58,0 -46,3 -25.2% | -20,9 -21,5 3% | -7,60 -8,17 7.04% | -17,4 |
|
EPS USD | Released Forecast Spread | -342 | -194 -6,75 -2766.67% | -61,8 -49,4 -25.1% | -19,8 -20,1 1.49% | -5,64 -6,00 6% | -10,8 |
| Announcement Date | 27/03/20 | 16/04/21 | 28/03/22 | 30/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,2 -6,84 -165.6% | -5,44 -7,45 26.95% | -3,01 -5,96 49.4% | -7,02 -3,83 -83.15% | -5,78 -5,73 -0.93% | -3,67 -5,70 35.7% | -3,62 -4,15 12.75% | -3,12 -3,95 20.96% | -3,17 -3,54 10.43% | -3,88 | -4,21 | -4,52 | -4,81 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,0 -6,56 -174.68% | -5,44 -7,33 25.82% | -2,98 -5,93 49.76% | -6,88 -3,77 -82.4% | -5,58 -6,23 10.35% | -0,23 -6,00 96.22% | -1,99 -4,10 51.41% | -2,42 -3,95 38.84% | -2,96 -3,54 16.26% | -3,88 | -4,21 | -4,52 | -4,81 |
|
Net income Million USD | Released Forecast Spread | -18,0 -6,73 -167.95% | -5,44 -7,33 25.82% | -2,98 -5,93 49.76% | -6,88 -3,77 -82.4% | -5,58 -6,23 10.35% | -0,23 -6,00 96.22% | -1,99 -4,10 51.41% | -2,42 -3,95 38.84% | -2,96 -3,54 16.26% | -3,88 | -4,21 | -4,52 | -4,81 |
|
EPS USD | Released Forecast Spread | -15,6 -6,20 -151.61% | -5,10 -6,90 26.09% | -3,00 -5,40 44.44% | -6,60 -3,30 -100% | -5,40 -5,70 5.26% | -0,30 -4,80 93.75% | -1,50 -3,00 50% | -1,80 -3,00 40% | -5,52 -2,70 -104.44% | -2,70 | -2,70 | -2,70 | -3,00 |
| Announcement Date | 28/03/22 | 16/05/22 | 15/08/22 | 31/10/22 | 30/03/23 | 15/05/23 | 07/08/23 | 01/11/23 | 26/03/24 | - | - | - | - |
More events
Past sector events for GT Biopharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GTBP Stock
- Calendar GT Biopharma, Inc.